Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How to facilitate the wider use of pharmacogenetic tests?
Verstuyft C, Dewolf D, Blin O, Florentin V, Mesnard L, Chaumette B, Ayme-Dietrich E, Raymond L, Lang M, Lamazière A, Allard B, Samelson L, Lamezec L, Loriot MA, Le Bozec A, Picard N. Verstuyft C, et al. Among authors: ayme dietrich e. Therapie. 2024 Dec 20:S0040-5957(24)00215-4. doi: 10.1016/j.therap.2024.11.010. Online ahead of print. Therapie. 2024. PMID: 39788802
Comment faciliter la diffusion des tests de pharmacogénétique ?
Verstuyft C, Dewolf D, Blin O, Florentin V, Mesnard L, Chaumette B, Ayme-Dietrich E, Raymond L, Lang M, Lamazière A, Allard B, Samelson L, Lamezec L, Loriot MA, Le Bozec A, Picard N. Verstuyft C, et al. Among authors: ayme dietrich e. Therapie. 2024 Dec 5:S0040-5957(24)00209-9. doi: 10.1016/j.therap.2024.11.007. Online ahead of print. Therapie. 2024. PMID: 39710540 French. No abstract available.
French-Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.
Lebreton L, Boyer JC, Lafay-Chebassier C, Hennart B, Baklouti S, Cunat S, Vilquin P, Medard Y, Gautier-Veyret E, Laffitte-Redondo C, Verstuyft C, Ait Tayeb AEK, Haufroid V, Wils J, Lamoureux F, Evrard A, Davaze-Schneider J, Ben-Sassi M, Picard N, Quaranta S, Ayme-Dietrich E; French‐Speaking Network of Pharmacogenetics (RNPGx). Lebreton L, et al. Among authors: ayme dietrich e. Clin Pharmacol Ther. 2024 Nov 25. doi: 10.1002/cpt.3502. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 39584620 Review.
A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis.
Collongues N, Becker G, Jolivel V, Ayme-Dietrich E, de Seze J, Binamé F, Patte-Mensah C, Monassier L, Mensah-Nyagan AG. Collongues N, et al. Among authors: ayme dietrich e. Neurol Ther. 2022 Sep;11(3):981-1042. doi: 10.1007/s40120-022-00363-7. Epub 2022 May 24. Neurol Ther. 2022. PMID: 35610531 Free PMC article. Review.
Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France.
Becker G, Martin T, Sabo AN, Bertrand F, Hutt A, Ayme-Dietrich E, Michel B, Monassier L, Gourieux B. Becker G, et al. Among authors: ayme dietrich e. Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):1158-1162. doi: 10.26355/eurrev_202101_24686. Eur Rev Med Pharmacol Sci. 2021. PMID: 33577072 Free article.
25 results